AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Business Of Biotech
Mission-Driven Dementia Funding with DDF's Jonathan Behr
Jun 10, 2024
Jonathan Behr, MIT Ph.D. in biological engineering turned venture capitalist, discusses dementia funding, biotech corporate finance, & entrepreneurship. Highlights include strategic investments in dementia research, diversification in funding modalities, challenges in developing disease-modifying drugs, and the importance of a translational mindset in the biotech industry.
55:46
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Mission-driven venture capital is crucial for biotech startups addressing cognitive disorders.
- Transitioning from academia to venture capital requires diverse experiences to bridge science and business in biotech.
Deep dives
Venture Capital Trends in Biotech Startups
Mission-driven venture capital is becoming a prominent financial support avenue for biotech startups, particularly focusing on cognitive disorders. With the global dementia-affected population expected to double every 20 years, the biotech industry is responding with potential projections for the dementia therapeutics market to surpass $30 billion by 2030. Understanding the science and markets proves vital in capitalizing on this industry landscape.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode